An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 2, Pages 553-557
Publisher
American Society for Clinical Investigation
Online
2012-01-03
DOI
10.1172/jci59309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
- (2011) J. R. Adams et al. CANCER RESEARCH
- Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
- (2011) D. S. Meyer et al. CANCER RESEARCH
- In Vivo Activity of Combined PI3K/mTOR and MEK Inhibition in a KrasG12D;Pten Deletion Mouse Model of Ovarian Cancer
- (2011) K. M. Kinross et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
- (2011) Pixu Liu et al. NATURE MEDICINE
- PI(3)King Apart PTEN's Role in Cancer
- (2010) S. Zhang et al. CLINICAL CANCER RESEARCH
- The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
- (2010) E. Despierre et al. GYNECOLOGIC ONCOLOGY
- Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis
- (2010) Manasa Ramakrishna et al. PLoS One
- Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design
- (2010) Hengmiao Cheng et al. MedChemComm
- Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation
- (2009) Shun Liang et al. PLoS One
- Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas
- (2009) Katherine V. Clark-Knowles et al. PLoS One
- Large-scale genomic analysis of ovarian carcinomas
- (2008) Kylie L. Gorringe et al. Molecular Oncology
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search